Ignite Creation Date:
2024-05-06 @ 7:24 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02523014
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2015-08-11
Brief Title:
Vismodegib FAK Inhibitor GSK2256098 Capivasertib and Abemaciclib in Treating Patients with Progressive Meningiomas
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Alliance for Clinical Trials in Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10
Completion Date Type:
ESTIMATED
First Submit Date:
2015-08-11
First Submit QC Date:
August 12 2015
Study First Post Date:
2015-08-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-03
Last Update Post Date:
2024-05-23
Last Update Post Date Type:
ACTUAL